Entering text into the input field will update the search result below

JP Morgan physician survey finds support for Lilly's donanemab in Alzheimer's

  • A survey JP Morgan conducted of 25 U.S. physicians familiar with Alzheimer's disease found there there is a clear need for a drug that provides even a modest level of treatment benefit.
  • Results indicated that the doctors see broad utilization

Recommended For You

Related Stocks

SymbolLast Price% Chg
BIIB
--
LLY
--
ESALF
--